Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction (CARE-AMI): a Randomized Controlled Pilot Study
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Paroxetine (Primary)
- Indications Anxiety disorders
- Focus Pharmacodynamics
- Acronyms CARE-AMI
- 04 Feb 2019 Planned End Date changed from 1 Dec 2018 to 1 Feb 2020.
- 04 Feb 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Feb 2020.
- 10 Oct 2017 Status changed from not yet recruiting to recruiting.